Summary
                        
        
                            Kinase inhibitors (KIs) represent a clinically important class of anticancer agents, as KIs have shown the potential for curative and long-term remission. Currently, there are 28 KIs on the market, and more than 150 KIs in clinical development. However, a major side effect of...
                    
    
        
                                 
                    More information & hyperlinks
                        
         
                             
                             
                            